Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

2′-Fucosyllactose inhibits human norovirus replication in human intestinal enteroids

10 Jan 2025

Abstract excerpt

Human noroviruses (HuNoVs) are the leading cause of acute gastroenteritis worldwide. Currently, there are no targeted antivirals for the treatment of HuNoV infection. Histo-blood group antigens (HBGAs) on the intestinal epithelium are cellular attachment factors for HuNoVs; molecules that block the binding of HuNoVs to HBGAs thus have the potential to be developed as antivirals. Human milk oligosaccharides (HMOs)...

Topics

Join the communities discussing this publication.

Infant Nutrition and Health
Respiratory viral infections research
Viral gastroenteritis research and epidemiology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39791912
DOI: 10.1128/jvi.00938-24

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

2′-Fucosyllactose inhibits human norovirus replication in human intestinal enteroidsPMID 39791912Read ↗

2’-Fucosyllactose Inhibits Human Norovirus Replication in Human Intestinal EnteroidsSemantic proximity Read ↗

Glycan Recognition in Human Norovirus InfectionsSemantic proximity Read ↗

Progress in the Development of Broadly Reactive Norovirus TherapeuticsSemantic proximity Read ↗

Human Milk Oligosaccharides as Promising AntiviralsSemantic proximity Read ↗

Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection.Semantic proximity Read ↗

Characterization of human norovirus binding to gut-associated bacterial ligandsSemantic proximity Read ↗

N-glycoproteomic analyses of human intestinal enteroids, varying in histo-blood group geno- and phenotypes, reveal a wide repertoire of fucosylated glycoproteins.Semantic proximity Read ↗

Determining the Importance of Carbohydrate-Based Structures in Murine Norovirus Binding to Commensal BacteriaSemantic proximity Read ↗

Development of a broad-spectrum therapeutic Fc-nanobody for human norovirusesSemantic proximity Read ↗

Human Noroviruses' Fondness for Histo-Blood Group AntigensSemantic proximity Read ↗

Genogroup IV and VI Canine Noroviruses Interact with Histo-Blood Group AntigensSemantic proximity Read ↗

The Role of Histo-Blood Group Antigens and Microbiota in Human Norovirus Replication in Zebrafish LarvaeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.